Replies to post #104 on Equity Field Notes from temporal sources

[DanWebzster]

MNLO dropped significantly on poor results for a Ph2 Atopic
Dermatitis study during 4/18

There are mitigating circumstances:
* It has recently reported positive Ph2s in two other indications
* Two more Ph2s are pending.

Cash on 12/31/17 was $62.5mn providing a runway thru 2018